The Missing Piece in Psychedelic Therapy: How We Make Meaning of What We Experience
There's a strange omission in much of the clinical literature on psychedelic therapy.
The research papers will tell you about neuroplasticity, about serotonin receptors, about the default mode network and predictive processing. They'll describe the symptom changes — depression scores dropping, anxiety subscales improving, addiction patterns loosening. The mechanism gets traced through brain imaging, neurotransmitter activity, network dynamics.
What they often don't address is what people actually experience.
Not the activated receptors. The sense of having met God, or having understood the universe, or having encountered a deceased grandmother, or having recognized that everything is connected, or having confronted their own mortality, or having seen, in a way they can't put into words, what their life is for. These aren't side effects of the medicine. For many people, they are the heart of what happened.
A 2023 paper in JAMA Psychiatry, Importance of Integrating Spiritual, Existential, Religious, and Theological Components in Psychedelic-Assisted Therapies, addresses this gap directly. The authors — Palitsky, Kaplan, Peacock, and colleagues — argue that the spiritual, existential, religious, and theological dimensions of psychedelic experience are not peripheral. They may be central to how healing actually happens. And current clinical models, by failing to systematically address them, are leaving a significant part of the work undone.
I want to walk through this carefully, because I think the paper is naming something that matters enormously for the future of psychedelic therapy — and for the broader question of what any depth-oriented therapy is actually for.
What Most Clinical Models Miss
Modern psychedelic therapy follows a three-phase structure: preparation, the experience itself, and integration. Within each phase, there's usually careful attention to safety, screening, expectation-setting, emotional support, and basic therapeutic principles.
What's often missing is a framework for working with the meaning-making that almost inevitably arises.
People emerge from psychedelic experiences having encountered material that doesn't fit neatly into clinical categories. I felt like I was dying, and it was okay. I saw what I came here to do. I forgave my mother in a way I never thought possible. I understood, for those hours, that love is the actual fabric of reality. I met a presence I can only call sacred.
These aren't symptoms to be managed. They're not delusions to be corrected. They're not metaphors to be translated into psychological terms. They are the substance of the experience for many people, and the work of integration involves figuring out what to do with them.
But the clinical models rarely address how. Most psychedelic therapy training, even in established programs, treats spiritual and existential material as something the therapist is expected to navigate intuitively, without formal preparation. Some therapists handle this well. Many handle it poorly — either dismissing the meaning-making as epiphenomenal, or unwittingly imposing their own metaphysical assumptions, or simply not knowing what to do when a patient describes experiences that exceed the framework they were trained in.
The JAMA paper proposes that this needs to change. Not because every patient is spiritual or religious, but because all patients are meaning-making creatures, and psychedelic experiences amplify exactly the dimensions of life where meaning is most actively constructed.
The SERT Framework
The paper organizes these dimensions into four overlapping domains, captured by the acronym SERT:
Spiritual — the felt sense of connection to something larger, sacred, or deeply meaningful. This doesn't require any particular belief system. Atheists, agnostics, and people of all religious traditions can have spiritual experiences in this sense.
Existential — the human confrontation with mortality, meaning, identity, freedom, and the basic conditions of existence. The questions that arise when ordinary distraction falls away and life's underlying realities become unavoidable.
Religious — the structured belief systems, communal practices, and cultural traditions through which many people have historically organized spiritual and existential experience. Religion provides language, ritual, and community for what would otherwise be entirely private.
Theological — the more developed attempts to articulate the nature of ultimate reality, the divine, and the structures that might lie beneath ordinary experience. The intellectual and philosophical work of trying to make sense of what's been encountered.
These four domains aren't separate compartments. They overlap and inform each other. Together, they describe the dimension of human life where deep meaning is made — the same dimension that psychedelic experiences so often touch directly.
What the paper argues is that clinical work with psychedelic experience that ignores all four of these dimensions isn't neutral. It's incomplete. And incomplete care, in vulnerable states, can do harm.
What Happens Without This Framework
Without a framework for meaning-making, several predictable problems emerge in psychedelic therapy.
Patients get left alone with experiences they can't make sense of. Someone has a profound mystical encounter during a session. They leave wanting to talk about it. The therapist, lacking framework or training, redirects toward symptom management or cognitive integration. The experience gets quietly sidelined. The patient is left to figure out what it meant on their own, often without the contemplative or theological resources to do this well.
Therapists impose their own beliefs. A therapist with no formal training in spiritual care will inevitably bring their own assumptions into the room. A secular materialist therapist may unconsciously communicate that the patient's mystical experience was just their brain doing something. A spiritually inclined therapist may encourage interpretations that align with their own beliefs. Neither is neutral. Both can shape, sometimes coercively, what the patient comes to believe about their own experience.
Patients with religious frameworks get inadequate support. A devout Christian who has a psychedelic experience that doesn't fit her theology may feel deeply disoriented. A Jewish patient who encounters something that feels like the divine may need to integrate that within his existing spiritual life. Many clinical settings have no infrastructure for engaging with these specific religious frameworks, even though the patient's religious life is often centrally relevant to how they'll integrate the experience.
Atheists and secular patients get inadequate support too. A secular patient may have an experience that destabilizes their worldview. They emerge convinced of things they didn't believe before. Without help, they may either uncritically adopt new metaphysical commitments or repress what they experienced because it doesn't fit their existing framework. Either response leaves the integration incomplete.
Spiritual distress goes unaddressed. Not all psychedelic experiences are positive. Some involve profound existential distress — feeling abandoned by God, encountering darkness that doesn't resolve, losing a faith that previously felt secure, confronting mortality in ways that produce lasting fear. Clinicians without training in spiritual care often don't recognize these as the spiritual emergencies they are, and the patient is left without adequate support.
The paper documents that all of these problems are common in current psychedelic therapy. They're not edge cases. They're routine consequences of clinical models that treat meaning-making as someone else's problem.
Why Psychedelics Specifically Amplify This Need
There's a specific reason this matters more in psychedelic therapy than in many other forms of clinical work.
Psychedelics, neurologically, increase what researchers call cognitive flexibility and suggestibility. The rigid filters through which we ordinarily organize experience loosen. New patterns can form. Existing patterns can be revised.
This is part of what makes the medicines therapeutically valuable. It's also what makes them ethically demanding. In a state of increased suggestibility, what the patient is exposed to — including what the therapist says, what the music suggests, what the cultural context implies, what the patient already half-believed — has unusual influence. The window in which new meaning gets made is unusually wide.
For meaning-making specifically, this matters enormously. The interpretations a patient forms during and immediately after a psychedelic experience often consolidate into how they'll understand the experience long-term. If those interpretations are guided thoughtfully, with attention to the patient's own values and tradition, integration tends to go well. If they're guided poorly, or not guided at all, the patient may end up with conclusions that don't serve them — sometimes with effects that persist for years.
This is part of why psychedelic therapy isn't just pharmacology. It's a kind of clinical work where the meaning context the therapist creates is itself part of the medicine. Or, when handled badly, part of the harm.
The Particular Difficulty for Therapists
I want to be honest about how difficult this is from the therapist's side.
Most therapists are trained, appropriately, in maintaining a kind of neutrality about patients' spiritual and existential lives. We're taught not to impose our own beliefs, not to evaluate the truth of religious convictions, not to direct patients toward particular metaphysical conclusions. This neutrality serves patients well in most clinical settings.
But psychedelic therapy challenges this stance in specific ways. Patients in altered states are bringing material that requires engagement. They're often asking, sometimes directly, what their therapist makes of what just happened. They want to know if it was real. They want to know what to do with it. They want help making sense of an experience that doesn't fit easily into their existing frameworks.
A therapist who maintains complete neutrality in this context can come across as dismissive or absent. A therapist who engages without care can impose. Finding the middle path — being substantively present without becoming directive — requires both training and personal preparation that most current programs don't adequately provide.
The paper's recommendation is that psychedelic-assisted therapy programs need to systematically include training in spiritual and existential care. Not turning therapists into chaplains or spiritual directors, but giving them the tools to recognize when these dimensions are active, to support patients in their own meaning-making rather than imposing the therapist's, and to refer or consult when more specific religious or spiritual expertise is needed.
How This Might Look in Practice
What would good integration of meaning-making look like in psychedelic therapy?
A few possibilities, drawn from the paper and from clinical practice:
Preparation that includes meaning. Before the session, exploring with patients what meaning systems they already work within. What gives their life meaning now? What spiritual or religious frameworks have shaped them? What existential questions have they been sitting with? What would they like to be open to during the experience? This gives the therapist a sense of the patient's existing meaning architecture, which helps the integration that comes later.
Non-directive presence during the experience. Skilled facilitators learn to support whatever arises without steering it toward particular interpretations. Notice what's here. Be with what comes. Let it move you wherever it wants to move you. The work isn't to install meaning; it's to make space for the patient's own meaning to emerge.
Integration that honors the meaning as well as the symptoms. After the experience, integration sessions should make explicit room for the spiritual and existential material, not just the psychological. What did you experience that felt sacred? What questions does this raise for you about your life? Has anything shifted in how you understand your purpose, your relationships, your mortality? These are integration questions, not just clinical ones.
Referral and consultation when needed. Therapists shouldn't be expected to be experts in every religious tradition, every theological framework, every philosophical system. Building referral networks with chaplains, spiritual directors, religious teachers, and contemplative practitioners — who can be consulted as appropriate to the patient's tradition — should be part of good psychedelic therapy infrastructure.
Honest acknowledgment of the limits. A therapist isn't a theologian or a spiritual teacher. Being clear about what the therapist can and cannot offer, and supporting patients in finding the right resources for the meaning-making questions they're sitting with, is itself part of responsible care.
A Wider Lens
What I find most clinically valuable about the JAMA paper is something its authors only touch on implicitly: this isn't really a problem specific to psychedelic therapy.
It's a problem in most contemporary mental health care.
For most of the 20th century, clinical psychology distanced itself from religious and spiritual frameworks as a way of establishing itself as a serious science. The cost was that the meaning-making dimension of human life — the dimension where mortality, purpose, identity, and the sacred live — got increasingly handed off to people who weren't psychologically trained, or simply got ignored.
This worked, sort of, in eras when most patients had robust religious frameworks of their own. People could do the meaning-making outside therapy — in church, in community, in the structured rituals of their tradition. Therapy could focus on the psychological without addressing the existential, because the existential was being addressed elsewhere.
That arrangement has been quietly breaking down for decades. Many of my patients don't have religious frameworks they're embedded in. Many were raised in traditions they've left and haven't replaced. Many are spiritually serious but unaffiliated. Many are atheists or agnostics for whom existential questions remain real even without a religious context. The meaning-making dimension of their lives has nowhere external to land. It's all happening inside, often unsupported, often in the form of low-grade chronic distress that gets called depression or anxiety because we don't have better language for it.
This is part of why so many people are turning toward psychedelic therapy, contemplative practice, indigenous traditions, and other forms of meaning-making that the mainstream mental health system hasn't been able to provide. Not because traditional therapy is failing on its own terms, but because the existential dimensions of suffering aren't being addressed anywhere, and people are starving for them.
What the JAMA paper is naming, specifically about psychedelic therapy, is a broader truth: good care of human suffering eventually has to include the meaning-making dimension. The depression isn't only chemical. The anxiety isn't only cognitive. The grief isn't only emotional. Underneath, in most of the people I see, are existential and spiritual questions that need to be honored, examined, and supported.
What This Means for Path of the Pearl's Work
This is part of why I work the way I do.
Path of the Pearl is anticipating a future in which psilocybin and other psychedelic medicines will be legally available for therapeutic use in California. The technical aspects of that work — preparation, safety, dose, integration — matter enormously. But they're not the whole picture.
The deeper work, in my view, is creating clinical space where the spiritual, existential, and meaning-making dimensions of psychedelic experience can be held with care. Not by imposing any particular framework. Not by claiming expertise in any patient's specific tradition. But by recognizing that these dimensions are active in almost every meaningful psychedelic experience, by being able to sit with them without flinching or directing, and by helping each patient find their own way through what's been opened.
This requires training beyond standard clinical psychology. It requires the therapist's own contemplative and existential work. It requires building relationships with chaplains, spiritual directors, and teachers across traditions who can be consulted appropriately. It requires honesty about the limits of what any one practitioner can offer.
For me, this isn't a separate add-on to clinical work. It's part of what depth-oriented therapy has always been about, made more visible by the demands of working with psychedelic experiences. The same questions that arise vividly under the medicine — what is my life for? what happens when I die? what is sacred? who am I underneath the story I've been telling? — are quietly present in most of the work I do, whether or not any medicine is involved.
A Closing Reflection
The JAMA paper's central argument is, in a way, an old one dressed in clinical language. Healing is not just biological. It's not even just psychological. It's also about how we make sense of being alive — what we take to be sacred, what we believe gives our lives meaning, how we understand our place in the larger reality we're part of.
For thousands of years, traditional cultures have known this. The healing arts were embedded in larger frameworks of meaning — religious, communal, ceremonial. Modern Western medicine separated the biological from the spiritual for good reasons, but at a cost.
Psychedelic therapy is, in some sense, forcing the conversation back to where it needs to be. The medicines produce experiences that won't fit into purely biological or psychological frameworks. They demand to be addressed at the level where meaning is made. Clinicians who try to work with these medicines while avoiding the meaning-making dimension are increasingly recognizing that they can't.
This is hopeful, I think. Not because it means we're returning to pre-modern frameworks, but because we're being asked to develop new ones — frameworks that take both science and meaning seriously, that honor both the brain and the soul, that can hold both the patient's symptoms and their deepest questions.
The work is just beginning. The current clinical models are inadequate to it. But the direction is clear, and the resources — from contemplative traditions, from existential psychology, from interfaith chaplaincy, from indigenous wisdom traditions — are available. The question is whether the field can grow into them.
If you'd like to explore what depth-oriented work that honors the meaning-making dimension might look like for you, you're welcome to book a consultation.